Ozempic-maker sees Singapore as a platform to pilot treatments for diabetes, obesity
Singapore’s diabetes epidemic is not going away any time soon, and the wide pool of patients in a country with high-quality medical care and research makes it an ideal platform to pilot new forms of…
Read full story ->